The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota
- PMID: 24576788
- PMCID: PMC4076144
- DOI: 10.1016/j.cardfail.2014.02.007
The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota
Abstract
Background: Diabetic cardiomyopathy defined as either systolic or diastolic dysfunction in otherwise healthy diabetic persons is not clearly understood. The prevalence and outcomes of this disease in a community-based population have not been defined.
Methods and results: Cross-sectional survey of 2042 randomly selected residents of Olmsted County, Minnesota, aged 45 years or older between June 1997 and September 2000. All patients underwent Doppler echocardiographic assessment of systolic and diastolic function. Diabetic cardiomyopathy was defined in a person with diabetes and any systolic or at least moderate diastolic dysfunction without a history of coronary disease, hypertension, significant valvular disease, or congenital heart disease. The diagnosis of diabetic cardiomyopathy was made in 23 people, corresponding to a community population prevalence rate of 1.1%. Among diabetic patients, 16.9% met criteria for diabetic cardiomyopathy and 54.4% had diastolic dysfunction. Diabetes was associated with a 1.9-fold increase in risk of any left ventricular dysfunction, a 1.7-fold increase in risk of diastolic dysfunction, and a 2.2-fold increase in risk of systolic dysfunction. Among patients with diabetic cardiomyopathy, the cumulative probability of death was 18%, development of heart failure was 22%, and development of death or heart failure was 31% at 9 years.
Conclusion: Diabetic cardiomyopathy is relatively common in the community with a prevalence of 1.1%. The morbidity and mortality of patients with diabetic cardiomyopathy is high.
Keywords: Diabetes mellitus; Olmsted County; diabetic cardiomyopathy; heart failure; left ventricular dysfunction; prevalence.
Copyright © 2014 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures




Similar articles
-
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota.Circulation. 2007 Apr 17;115(15):1982-90. doi: 10.1161/CIRCULATIONAHA.106.659763. Epub 2007 Apr 2. Circulation. 2007. PMID: 17404159 Free PMC article.
-
Diabetes Mellitus Is an Independent Predictor for the Development of Heart Failure: A Population Study.Mayo Clin Proc. 2020 Jan;95(1):124-133. doi: 10.1016/j.mayocp.2019.07.008. Mayo Clin Proc. 2020. PMID: 31902407 Free PMC article.
-
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.JAMA. 2003 Jan 8;289(2):194-202. doi: 10.1001/jama.289.2.194. JAMA. 2003. PMID: 12517230
-
The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis.Diab Vasc Dis Res. 2018 Nov;15(6):477-493. doi: 10.1177/1479164118787415. Epub 2018 Jul 24. Diab Vasc Dis Res. 2018. PMID: 30037278 Free PMC article.
-
Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.Curr Med Chem. 2018;25(13):1510-1524. doi: 10.2174/0929867324666170705111356. Curr Med Chem. 2018. PMID: 28685679 Review.
Cited by
-
Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats.J Diabetes Res. 2018 Oct 14;2018:9232065. doi: 10.1155/2018/9232065. eCollection 2018. J Diabetes Res. 2018. PMID: 30406151 Free PMC article.
-
SGLT2 inhibition and heart failure-current concepts.Heart Fail Rev. 2018 May;23(3):409-418. doi: 10.1007/s10741-018-9703-2. Heart Fail Rev. 2018. PMID: 29704192 Review.
-
Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond.Heart Int. 2024 Dec 4;18(2):7-13. doi: 10.17925/HI.2024.18.2.2. eCollection 2024. Heart Int. 2024. PMID: 39885933 Free PMC article. Review.
-
Diabetic cardiomyopathy: a brief summary on lipid toxicity.ESC Heart Fail. 2023 Apr;10(2):776-790. doi: 10.1002/ehf2.14224. Epub 2022 Nov 11. ESC Heart Fail. 2023. PMID: 36369594 Free PMC article. Review.
-
The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications.Oxid Med Cell Longev. 2022 Sep 6;2022:3790721. doi: 10.1155/2022/3790721. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36111168 Free PMC article. Review.
References
-
- Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979;59:8–13. - PubMed
-
- Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: as statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–1146. - PubMed
-
- Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV, et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol. 2001;37:1943–1949. - PubMed
-
- Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, et al. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J. 1997;133:36–43. - PubMed
-
- Bella JN, Devereux RB, Roman MJ, Palmieri V, Liu JE, Paranicas M, et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study) Am J Cardiol. 2001;87:1260–1265. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous